Product Description
The therapeutic benefits of controlling the fibrinolytic process are becoming well known. Its implications for and applications to clinical medicine continue to expand, and this book aims to provide a review of this therapeutic measure. It presents recent information on the subject: basic science of fibrinolysis, thrombosis and haemostasis; the rationale underlying the the activation and inhibition of the fibrinolytic enzyme system in the management of a variety of thrombotic and haemostatic disorders; evaluation of the clinical benefits and adverse reactions associated with thrombolytic agents; and guidelines for patient selection, drug administration, management and follow-up therapy. This book is intended for cardiologists, internists and haematologists.







